We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

112 hedge funds and large institutions have $1.52B invested in Clovis Oncology, Inc. in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 21 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 21

11% more capital invested

Capital invested by funds: $1.36B → $1.52B (+$153M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less funds holding

Funds holding: 116 → 112 (-4)

16% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 25

34% less call options, than puts

Call options by funds: $9.63M | Put options by funds: $14.6M

Holders
112
Holders Change
-4
Holders Change %
-3.45%
% of All Funds
3.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
21
Increased
60
Reduced
21
Closed
25
Calls
$9.63M
Puts
$14.6M
Net Calls
-$4.98M
Net Calls Change
-$3.87M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$30.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$28.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.1M
4
BBA
Baker Bros. Advisors
New York
+$12.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$23.4M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$10.3M
3
PA
Perceptive Advisors
New York
-$8.93M
4
HM
HealthCor Management
New York
-$8.56M
5
BIM
Bogle Investment Management
Massachusetts
-$5.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
76
American International Group
New York
$751K +$171K +3,137 +34%
Wells Fargo
77
Wells Fargo
California
$728K +$35.5K +652 +6%
First Trust Advisors
78
First Trust Advisors
Illinois
$707K +$317K +5,820 +98%
DCM
79
Driehaus Capital Management
Illinois
$674K -$2.89M -53,202 -83%
Citigroup
80
Citigroup
New York
$658K +$10.2K +187 +2%
Barclays
81
Barclays
United Kingdom
$645K -$205K -3,762 -26%
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$630K +$537K +9,876 +1,721%
VOYA Investment Management
83
VOYA Investment Management
Georgia
$604K +$59.1K +1,087 +12%
BCM
84
Bourgeon Capital Management
Connecticut
$452K +$408K +7,500 New
BG
85
BlackRock Group
United Kingdom
$433K -$1.29M -23,798 -77%
UBS AM
86
UBS AM
Illinois
$428K +$131K +2,400 +51%
AAP
87
Ardsley Advisory Partners
Connecticut
$422K +$381K +7,000 New
KBC Group
88
KBC Group
Belgium
$388K +$350K +6,437 New
III
89
Independent Investors Inc
New York
$361K – – –
DCM
90
Dupont Capital Management
Delaware
$348K -$48.6K -894 -13%
GCP
91
GSA Capital Partners
United Kingdom
$340K +$34.6K +637 +13%
Ameriprise
92
Ameriprise
Minnesota
$338K -$520K -9,557 -63%
PAM
93
Paradigm Asset Management
New York
$322K – – –
Group One Trading
94
Group One Trading
Illinois
$268K +$242K +4,454 New
Citadel Advisors
95
Citadel Advisors
Florida
$261K +$236K +4,332 New
GLRA
96
Gerald L. Ray & Associates
Texas
$259K +$234K +4,300 New
TAM
97
Tocqueville Asset Management
New York
$247K +$223K +4,100 New
QIM
98
Quantitative Investment Management
Virginia
$222K +$201K +3,700 New
Morgan Stanley
99
Morgan Stanley
New York
$186K -$3.14M -57,657 -95%
NTCOC
100
Northern Trust Company of Connecticut
Connecticut
$184K – – –
2 3
4
5 6

CLVS Hedge Fund Activity: Q4 2013 in Review

112 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2013, worth a combined $1.52B — up 11% from $1.36B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of CLVS and 21 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 60 added.

The largest buyer was PFM Health Sciences, adding an estimated $30.3M. The largest seller was AllianceBernstein, cutting an estimated $23.4M.

  • 112 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2013, down from 116 in Q3 2013.
  • Funds reported $1.52B of Clovis Oncology, Inc. stock for Q4 2013, up 11% quarter-over-quarter.
  • 21 funds opened new Clovis Oncology, Inc. positions in Q4 2013 and 25 closed out, a net change of -4 holders.
  • The largest Clovis Oncology, Inc. buyer in Q4 2013 was PFM Health Sciences, an estimated $30.3M added.
  • The largest Clovis Oncology, Inc. seller in Q4 2013 was AllianceBernstein, an estimated $23.4M sold.

Based on aggregated 13F filings for Q4 2013.